Investing.com -- President Donald Trump said on Thursday that the United States is having good talks with Iran and needs to make a meaningful deal with the Middle Eastern country. Trump made these ...

Investing.com -- AppLovin Corp. is developing a social networking platform following its unsuccessful attempt to acquire TikTok’s non-Chinese assets last year.

Investing.com -- Energy Services of America Corporation (NASDAQ:ESA) stock dropped 6% on Thursday after the company announced the pricing of an underwritten public offering of common stock. The ...

Investing.com -- Traws Pharma Inc (NASDAQ:TRAW) stock plunged 27% Thursday after the company announced that the FDA has placed its influenza treatment candidate tivoxavir marboxil on clinical hold.

Investing.com -- Federal Reserve Bank of Minneapolis President Neel Kashkari delivered pointed criticism of cryptocurrency while defending the Fed’s independence during a speaking engagement in North ...

Figure Technology Solutions (NASDAQ:FIGR) launched FGRD, the first SEC-registered public equity to be natively issued and settled entirely on blockchain infrastructure, on Thursday. FGRD shares are ...

Scopely, a U.S. mobile gaming studio that publishes popular games like "Monopoly Go!" and "Pokémon Go," is owned by Savvy Games Group, a subsidiary of Saudi Arabia’s Public Investment Fund. The ...

The company is selling 6,428,574 common shares at a price of $7.00 per share and pre-funded warrants to purchase up to 1,428,571 common shares at $6.99999 per warrant. The offering is expected to ...

Investing.com -- Jiuzi Holdings Inc (NASDAQ:JZXN) stock surged 22.4% in Thursday’s premarket trading after the company announced it is in discussions to expand its recent private placement offering to ...

Moleculin is currently advancing a Phase 3 clinical trial called MIRACLE, evaluating its lead program Annamycin in combination with cytarabine for the treatment of relapsed or refractory acute myeloid ...

Investing.com -- PMGC Holdings Inc (NASDAQ:ELAB) stock surged 9.8% in premarket trading Thursday after its subsidiary NorthStrive Biosciences announced the filing of ten new U.S. patent applications ...

Despite the earnings beat, investors appeared concerned about the company’s outlook. Garrett Motion projected fiscal 2026 revenue between $3.6 billion and $3.8 billion, which aligns with analyst ...